FDA Investigator Iram R Hassan, PhD
Iram R Hassan, PhD has conducted inspections on 131 sites in 9 countries as of 06 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
131
Last Inspection Date:
06 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Poland,
Canada,
Germany,
Norway,
Brazil,
France,
India,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Iram R Hassan, PhD:
Alia Legaux,
Alice S Tsao,
Althea A Williams,
Amanda E Lewin, PhD,
Amanda T Zick,
Amatul H Marium,
Amber D Brodas,
Amy Kim,
Amy Wyan Mai,
Andrew B Paglia, DPM,
Andrew F Cohen,
Andrew J Garufi,
Andrew M Abramowitz,
Ann B Borromeo,
Ann M Stewart,
Arthur S Williams, Jr,
Ashley Defilippis,
Aziz A Mamur,
Barbara D Wright,
Bei Yu,
Benton M Ketron,
Bernardica T Sculac Stern,
Betty M Ng Lee,
Bijoy Panicker,
Brandy D Brown,
Brian M Brodman,
Byungja E Marciante,
Cara M Minelli,
Carmen Y Fisher,
Carrie E Jolly,
CDR Ileana Barreto Pettit,
Charanjeet Jassal,
Charisse K Green,
Christian Parra,
Christine M Rivera,
Christopher B May,
Christopher S Fields,
Claudette D Brooks,
Coleburn E Vielehr,
Courtney N Long,
Craig T Rybus,
Ct Viswanathan, PhD,
Dave M Deroche,
David R Delucia,
Dawn C Olenjack,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Denise R Beuttenmuller,
Diane Cvan Leeuwen,
Dilijeta Bajrami,
Dongping Dai, PhD,
Douglas G Ng,
Dr. Abhijit Raha, PhD,
Dr. Robert C Horan, MD,
Edouard Viard,
Emilio Z Azukwu,
Erica B Brush,
Erica B Raphael,
Evan Tong,
Evelyn Taha,
Felix Maldonado,
Frank Verni,
George C Amedro,
Gerald B Seaborn, Jr,
Gifford Whitehurst, Jr,
Gregson A Joseph,
Gwyn G Dickinson,
Harry J Brewer,
Hasan A Irier, PhD,
Hector Jcolon Torres,
Helen B Ricalde,
Irina Gaberman,
Jackson Y See,
Jacqueline S Warner,
James A Liubicich,
James I Giefer,
James L Dunnie, Jr,
James R Fleckenstein,
Jane C Chen,
Janete F Guardia,
Jason Kwong,
Jay T Wong,
Jennifer L Custodio,
Joanne M Schlossin,
Jogy George,
John B Crowe,
John P Shelton,
Jonathan D Green,
Jose Ohernandez Guzman,
Joseph Duca,
Joseph Maselli,
Joy P Matthias,
Juliana Falla,
Jung K Kim,
Karen L Kosar,
Karen M Cooper,
Kellie Leveille,
Kerry D Noto,
Kerun Hardeo,
Kevin A Gonzalez,
Kim Lthomas Cruse,
Kim M Downing,
Kimberley A Ricketts,
Kimberly A Benson,
Kimberly Y Smithson,
Kwong P Lee,
L Gnnmassimia Massimilla, PharmD,
Lata C Mathew, PhD,
Lawrence W Farina,
LCDR Chad N Thompson,
Leena Thomas,
Lisa Mathew,
Lorie S Hannappel,
LT Richard A Lyght,
LTJG Matthew R Palo,
Matthew A Spataro,
Matthew C Watson,
Melanie M Walker,
Melissa B Libby,
Melkamu Getie Kebtie, PhD,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael F Skelly, PhD,
Michael Levin,
Michael P Sheehan,
Michael R Dominick,
Michael Serrano,
Michele C Murray Schrade,
Michelle M Noe Varga,
Milan S Kunajukr,
Milan S Mcgorty,
Mindy M Chou,
Miral B Patel,
Mohsen Rajabi Abhari, FDA,
Neil J Bonzagni, PhD MPH,
Ni Aye Khin, MD,
Nicholas J Morici,
Nicole Vaught,
Nina Yang,
Noreen Muñiz,
Omadevi Somai, Investigator,
Osama A Khatib,
Patrick A Bowen,
Patrick C Klotzbuecher,
Paul M Gelfand,
Paul Mouris,
Pearl L Gonzalez,
Perry T Nichols,
Peter Abel,
Peter M Trunk,
Peter R Caparelli,
Peter S Diak,
Preston M Lee,
Rachael A Moliver,
Randolph Campos Santiago,
Raymond M Lam,
Renee S Blosser,
Rita F Monfort,
Robert C Steyert,
Robert E Moncayo,
Rochelle K Kimmel,
Roger F Zabinski,
Ronald Ifraimov,
Rose Xu,
Russ E Davis,
S Lori Brown, PhD MPH,
Samantha N Mccormick,
Sarah A Meehan,
Satheesh Thomas,
Scott B Laufenberg,
Shari L Kahn,
Shreya Shah,
Simone E Pitts,
Sonia E Ortiz,
Sony Mathews,
Sripal R Mada, PhD,
Stephanie T Durso,
Steven J Libal,
Stuart W Russell,
Sunita Vij,
Susan P Bruederle,
Susanne M Richardson, MS RAC,
Syeda N Mahazabin,
Taina Pierre Pierre,
Tamara M Simpson,
Tara K Carmody,
Tara K Normandin,
Tawny L Colling,
Theressa B Smith,
Thomas E Friel,
Thomas J Mooney,
Thomas P Hansen,
Traci C Kelm,
Tracy M Portelli,
Uduak M Inokon,
Valerie A Potopsingh,
Valerie Jgrecek Trinh,
Vanessa M Williams,
Vivin George,
Wayne J Meyer,
Xiaoping Guan,
Xikui Chen (nmi), PhD,
Yuyan Liang,
Yvesna C Blaise,
Zameer Farouk
Iram R Hassan, PhD's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more